Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that the European Commission has approved VIZIMPRO® (dacomitinib), a tyrosine kinase inhibitor…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, has expanded two additional cohorts from the Phase II SUMMIT…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc., a privately held, clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat…
Roche presents data from a mock clinical trial study suggesting that next-generation discovery proteomics is ready for use in clinical…
DUBLIN–(BUSINESS WIRE)–The “Cold and Sinus Medications Market in the United States” report has been added to ResearchAndMarkets.com’s offering. A comprehensive…
VANCOUVER, British Columbia–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/healthcare?src=hash" target="_blank"gt;#healthcarelt;/agt;–Reimbursement Tracker™ just announced the launch of their subscription platform designed to improve analysis and…
Leading AI healthcare innovator closes $15M round, led by Marubeni, Capitol Health, and private investors SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ArtificialIntelligence?src=hash" target="_blank"gt;#ArtificialIntelligencelt;/agt;–Enlitic,…
DUBLIN–(BUSINESS WIRE)–The “Alpha-Mannosidosis Global Clinical Trials Review, H2, 2018” clinical trials has been added to ResearchAndMarkets.com’s offering. “Alpha-Mannosidosis Global Clinical…
DUBLIN–(BUSINESS WIRE)–The “Cancer Profiling and Pathways: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. Cancer biomarkers have…
TORONTO–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/FSDDF?src=hash” target=”_blank”gt;#FSDDFlt;/agt;–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today the appointment…